Treatment options for human immunodeficiency virus.
Heins
J R
JR
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D016049:Didanosine / Q000627:therapeutic use; D017277:Drug Approval; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D019259:Lamivudine / Q000627:therapeutic use; D008297:Male; D019258:Saquinavir / Q000627:therapeutic use; D018119:Stavudine / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration; D016047:Zalcitabine / Q000627:therapeutic use; D015215:Zidovudine / Q000627:therapeutic use
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D019259:Lamivudine; D015215:Zidovudine; D016047:Zalcitabine; D018119:Stavudine; D016049:Didanosine; D019258:Saquinavir